Related Experiment Videos
Early prediction of severe acute cholecystitis using routine admission parameters: a study of 1,330 patients
Alparslan Ertenlice1,2, Hikmet Pehlevan Özel3, Zeynep Nur Yurdakul3
1Faculty of Medicine, Department of General Surgery, Ankara Yildirim Beyazit University, Ankara, Turkey. alparslanertenlice@aybu.edu.tr.
Insights
Predicting severe acute cholecystitis is possible using routine admission data. Advanced age, diabetes, low hemoglobin, and high CRP/albumin ratio (CAR) identify high-risk patients for early intervention.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Critical Care
- Clinical Chemistry
Background:
- Acute cholecystitis requires accurate risk stratification for optimal patient outcomes.
- Current diagnostic criteria may not fully capture all patients at high risk for severe disease progression.
- Early identification of severe acute cholecystitis is crucial for timely and appropriate clinical management.
Purpose of the Study:
- To identify independent predictors of severe acute cholecystitis among routine clinical, demographic, and laboratory admission parameters.
- To develop and validate a predictive model for early risk stratification of severe acute cholecystitis.
- To assess the clinical utility of identified predictors in guiding patient management.
Main Methods:
- Retrospective analysis of 1,330 adult patients diagnosed with acute cholecystitis (Tokyo Guidelines 2018).
- Logistic regression and ROC analyses were used to identify independent predictors, excluding direct TG18 Grade 3 indicators.
- Internal validation via bootstrap resampling and clinical utility assessment using decision curve analysis (DCA).
Main Results:
- Severe acute cholecystitis was present in 12.9% of the cohort.
- Independent predictors identified: CRP/albumin ratio (CAR), age, diabetes mellitus, and hemoglobin level.
- The predictive model showed moderate discriminatory power (AUC = 0.766); a CAR cut-off > 1.10 significantly increased severe disease likelihood.
Conclusions:
- Routine admission parameters including age, diabetes, hemoglobin, and CAR can effectively predict severe acute cholecystitis.
- This multivariable approach enhances early bedside risk stratification beyond standard Tokyo Guidelines 2018 assessment.
- The findings support improved clinical vigilance and timely intervention for high-risk patients.
Abstract:
To evaluate routine clinical, demographic, and laboratory admission parameters as independent predictors of severe acute cholecystitis to facilitate early risk stratification. A total of 1,330 adult patients diagnosed with acute cholecystitis according to the Tokyo Guidelines 2018 (TG18) were analyzed in this single-center, retrospective study between 2019 and 2024. Patients were classified into mild/moderate (Group 1) and severe (Group 2) cohorts. Independent predictors of severe acute cholecystitis were determined using logistic regression and ROC analyses. To avoid incorporation bias, variables directly defining TG18 Grade 3 organ dysfunction were excluded from the multivariate models. Furthermore, internal validation was performed via bootstrap resampling (1000 iterations), and clinical utility was assessed using decision curve analysis (DCA). Group 2 (severe disease) comprised 12.9% (n = 172) of the cohort. The severe group was significantly older with a higher prevalence of diabetes. In multivariate analysis, the CRP/albumin ratio (CAR), age, diabetes mellitus, and hemoglobin level were identified as independent predictors The model demonstrated stable, moderate discriminatory power (AUC = 0.766). A Youden-derived CAR cut-off of > 1.10 significantly increased severe disease likelihood. DCA confirmed the model yielded superior net clinical benefit across relevant threshold probabilities. The combination of advanced age, diabetes mellitus, lower hemoglobin levels, and elevated CAR can provide a practical supportive framework for predicting severe acute cholecystitis. Within this multivariable approach, these routine admission parameters may enhance early bedside risk stratification and guide clinical vigilance alongside standard TG18 assessment.
Related Concept Videos
Cholecystitis
Acute Pancreatitis II: Clinical Manifestations and Management
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Acute Pancreatitis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies